No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (8)
Sort:
#001 — 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
TABLET, EXTENDED RELEASE;ORAL | Approved: Feb 2, 1995
No patent or exclusivity listings for this strength.
#002 — 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Feb 2, 1995
#003 — 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Feb 2, 1995
#004 — 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Feb 2, 1995
#005 — 34MG
RLD
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 2, 2008
#006 — 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 2, 2008
#007 — 17MG
RLDAB
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 2, 2008
#008 — 8.5MG
RLDAB
0 patents0 exclusivities▾
TABLET, EXTENDED RELEASE;ORAL | Approved: Jan 2, 2008